Clinical Trial

Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales

Study acronym: OPTIC-19
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This retrospective cohort study aims to characterise outcomes for patients treated on an intensive care unit (ICU) with COVID-19 in England and Wales, one year after discharge from hospital. Outcomes will be compared with patients admitted as an emergency to an ICU for other conditions. The study will use existing national audit data linked to routine healthcare datasets.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT04838106
Lead Sponsor University of Oxford
Collaborators: Intensive Care National Audit & Research Centre
Conditions Covid19, Myocardial Infarction, Stroke, Critical Illness, Heart Failure, Deep Vein Thrombosis, Pulmonary Embolism, Renal Failure
Enrollment 319,600 participants
Start Date 2020-08-01
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-14